Perrigo Names New Executive Vice President

999

ALLEGAN —The Perrigo Co. (Nasdaq: PRGO;TASE) today announced the appointment of Douglas Boothe as executive vice president and general manager, Perrigo Pharmaceuticals, effective January 2013.

Perrigo’s Chairman, President and CEO Joseph C. Papa said, “Doug will leverage his strategic perspective, executional leadership and industry experience in our prescription pharmaceutical business, ensuring that the strong growth and profitability we have enjoyed will continue into the future, allowing us to bring more quality, affordable products to market for patients.”

Prior to joining Perrigo, Boothe served as chief executive officer of Actavis Inc., where he was responsible for all aspects of the company’s generics business in North America and Latin America, including sales, marketing, supply chain, quality, finance, legal, IT, regulatory affairs, human resources, and intellectual property. He also has served in strategic planning and business development leadership roles for Alpharma Inc., Pharmacia Corp. and Xerox Corp. Doug has a bachelor of science degree in mechanical and aerospace engineering from Princeton University and a master of business administration in marketing management and strategic planning from the University of Pennsylvania’s Wharton School of Business.

Facebook Comments